Workshop on the therapeutic use of bacteriophages
Date:
08/06/2015
Location:
European Medicines Agency, London, UK
On 8 June 2015, the European Medicines Agency is organising a workshop on the therapeutic use of bacteriophages, bringing together experts and stakeholders from the academic, industrial and regulatory sectors to discuss different aspects of using bacteriophages to treat bacterial infections. The aim is to proactively discuss current issues and open questions and reflect on potential ways forward for this therapy with various stakeholders.
-
List item
Workshop on the therapeutic use of bacteriophages - Summary (PDF/75.19 KB)
First published: 09/07/2015
Last updated: 09/07/2015
EMA/389257/2015 -
List item
Agenda - Workshop on the therapeutic use of bacteriophages (PDF/68.67 KB)
First published: 21/05/2015
Last updated: 05/06/2015
EMA/265715/2015 Corr. -
List item
Presentation - A historical overview of the therapeutic use of bacteriophages (Andrzej Gorski) (PDF/2.93 MB)
First published: 22/06/2015
Last updated: 22/06/2015 -
List item
Presentation - GMP phage production for clinical trials (Frenk Smrekar) (PDF/371.69 KB)
First published: 22/06/2015
Last updated: 22/06/2015 -
List item
Presentation - GMP phage production for clinical trials (Laurent Bretaudeau) (PDF/882.15 KB)
First published: 22/06/2015
Last updated: 22/06/2015 -
List item
Presentation - Current issues on quality of phage products (Alan Fauconnier) (PDF/1.02 MB)
First published: 22/06/2015
Last updated: 22/06/2015 -
List item
Presentation - Changing phage cocktails to match developing resistance (Gilbert Verbeken) (PDF/1.37 MB)
First published: 22/06/2015
Last updated: 22/06/2015 -
List item
Presentation - Considerations on regulatory aspects (Zigmars Sebris) (PDF/134.17 KB)
First published: 22/06/2015
Last updated: 22/06/2015 -
List item
Presentation - Current clinical evidence for the therapeutic use of bacteriophages (Xavier Wittebole) (PDF/2.18 MB)
First published: 22/06/2015
Last updated: 22/06/2015 -
List item
Presentation - Experience from the ongoing Phagoburn clinical trial (Patrick Jault) (PDF/5.92 MB)
First published: 22/06/2015
Last updated: 22/06/2015 -
List item
Presentation - Experience from the Phagorburn clinical trial (Jerome Gabard) (PDF/371.21 KB)
First published: 22/06/2015
Last updated: 22/06/2015